Lumida
/CTNM
⌘K
Contineum Therapeutics Inc

Contineum Therapeutics Inc

CTNM
$14.82USD+1.09%+0.16 today

MARKET CAP

557.5M

P/E (TTM)

FWD P/E

DAY RANGE

$15 – $15

52W RANGE

$9
$18

Buying

6

institutions

Selling

7

institutions

New Positions

0

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
JH

Janus Henderson Group Plc

Q1 2026

BUY5.47 M71.19 M+3.02 M+155.1%0.02%
BI

Blackrock, Inc.

Q2 2026

BUY2.06 M33.83 M+1.40 M+287.2%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL1.52 M24.96 M+-162.84 K+13.4%0.03%
PA

Perceptive Advisors LLC

Q2 2026

SELL1.26 M20.58 M+-1.26 M-37.3%0.31%
MM

Millennium Management LLC

Q2 2026

SELL931.71 K15.27 M+-603.74 K-23.9%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY396.35 K6.50 M+46.15 K+42.0%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

BUY278.96 K4.57 M+2.30 K+26.5%0.21%
EP

Eversept Partners, LP

Q2 2026

BUY148.02 K2.43 M+1.61 K+26.9%0.13%
RT

Renaissance Technologies LLC

Q2 2026

SELL67.30 K1.10 M+-2.10 K+21.7%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL25.78 K422.52 K+-59.11 K-61.9%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY13.48 K202.22 K+10.99 K+552.3%0.00%
RC

Ra Capital Management, L.P.

Q2 2026

SELL0.000.00+-1.30 M-100.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL0.000.00+-42.18 K-100.0%0.00%